Question 1

What is the catalog number for Microvesicles derived from human prostate adenocarcinoma (LnCAP cell line)?

Accepted Answer

The catalog number for Microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) is LEV-15.

Question 2

Is Microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) in stock?

Accepted Answer

Microvesicles derived from human prostate adenocarcinoma (LnCAP cell line) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 4

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 5

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Microvesicles derived from human prostate adenocarcinoma (LnCAP cell line)

Product Specifications

Frequently Asked Questions

Explore Other Products

CD106 / VCAM1 (1.4C3), CF640R conjugate, 0.1mg/mL

Ep-CAM / CD326 (VU-1D9), CF514 conjugate, 0.1mg/mL

CD81 / TAPA-1 (1.3.3.22), CF405M conjugate, 0.1mg/mL

Cytokeratin, LMW (AE-1), CF568 conjugate, 0.1mg/mL

CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL

CD47 (B6H12.2), CF405S conjugate, 0.1mg/mL